Eloxx Pharmaceuticals, Inc. (ELOX)
0.37
+0.01
(+2.78%)
USD |
OTCM |
May 29, 16:00
Eloxx Pharmaceuticals EPS Diluted (Quarterly) : -0.0779 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.2139 |
| CorMedix, Inc. | 0.4151 |
| Cannabis Global, Inc. | 0.00 |
| Breakthrough Chemistry, Inc. | 0.0035 |
| BioStem Technologies, Inc. | -0.5234 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.754M |
| Total Expenses (Quarterly) | 3.754M |
| Enterprise Value | -3.567M |
| Earnings Yield | -1.68K% |
| Normalized Earnings Yield | -1661.51 |